Ex vivo anchored PD‐L1 functionally prevent in vivo renal allograft rejection
Abstract Organ transplantation is the optimal treatment for patients with end‐stage diseases. T cell activation is a major contributing factor toward the trigger of rejection. Induction therapy with T cell depleting agent is a common option but increases the risk of severe systemic infections. The i...
Saved in:
Main Authors: | Zihuan Luo (Author), Tao Liao (Author), Yannan Zhang (Author), Haofeng Zheng (Author), Qipeng Sun (Author), Fei Han (Author), Maolin Ma (Author), Yongrong Ye (Author), Qiquan Sun (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting PD-1/PD-L1 inhibits rejection in a heterotopic tracheal allograft model of lung transplantation
by: Taisuke Kaiho, et al.
Published: (2023) -
Therapies for Chronic Allograft Rejection
by: Min Young Kim, et al.
Published: (2021) -
Hypoxia-induced PD-L1 expression and modulation of muscle stem cell allograft rejection
by: Jacob Raiten, et al.
Published: (2024) -
Osteochondral allograft and xenograft immunogenicity decrease following ex vivo tissue culture
by: Kate E. Birdwhistell, et al.
Published: (2023) -
Optimized nonionic emulsifier for the efficient delivery of astaxanthin nanodispersions to retina: in vivo and ex vivo evaluations
by: Lei Xu, et al.
Published: (2019)